Nasopharyngeal Carcinoma — Trials

Nasopharyngeal Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

702 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 246
Recruiting: 131
Ph III recruiting: 54
Growth YoY: +5.4%
Industry share: 8%
Top sponsor: Sun Yat-sen University
Termination share: 22.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (35)

clinicaltrialsPublishedShowing 1–11 of 11 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06479811	[212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers	recruiting	Phase 1	120	National Cancer Institute (NCI)NIH	1	Sep 29, 2026	clinicaltrials
NCT07625423	Intratumoral Injection of Recombinant Human Endostatin Adenovirus (EDS01) for the Treatment of Recurrent or Metastatic Head and Neck Tumors(EDS01 HN)	recruiting	Phase 1	9	West China HospitalOTHER